On ECHEMI
Home > Drugs > Jincheng Haisi Pharmaceutical Co., Ltd.
Jincheng Haisi Pharmaceutical Co., Ltd.
  • Founded in:

    1997-12-30
  • Country:

    China China
  • Address:

    Wangtai, Jincheng City, Shanxi Province
  • Tax NO.:

    91140500111208832X
  • Registered Funds:

    148.512131 yuan
  • Email:

Related Drugs
Ofloxacin for injection
The main ingredient of this product is ofloxacin.
Name Description Content CAS NO. Registered Holders
Ofloxacin

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial activity against most bacteria of the Enterobacteriaceae family, Pseudomonas aeruginosa, and methicillin-sensitive Staphylococcus. It has good antimicrobial effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibits DNA synthesis and replication, and causes bacterial death. At present, there is an increasing trend in clinical drug resistance, and there is cross-resistance with other quinolones.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial activity against most bacteria of the Enterobacteriaceae family, Pseudomonas aeruginosa, and methicillin-sensitive Staphylococcus. It has good antimicrobial effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibits DNA synthesis and replication, and causes bacterial death. At present, there is an increasing trend in clinical drug resistance, and there is cross-resistance with other quinolones.

82419-36-1 30
Ofloxacin for injection
The main ingredient of this product is ofloxacin.
Name Description Content CAS NO. Registered Holders
Ofloxacin

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative rods, and has good antibacterial activity against the following bacteria in vitro: 1. Most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It also has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae, and Moraxella. 2. It has antibacterial activity against most strains of Pseudomonas, such as Pseudomonas aeruginosa. 3. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. 4. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. The drug resistance of this product is currently increasing, and there is cross-resistance with other quinolones.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative rods, and has good antibacterial activity against the following bacteria in vitro: 1. Most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It also has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae, and Moraxella. 2. It has antibacterial activity against most strains of Pseudomonas, such as Pseudomonas aeruginosa. 3. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. 4. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. The drug resistance of this product is currently increasing, and there is cross-resistance with other quinolones.

82419-36-1 30
Compound Glycyrrhizic Acid Monoammonium S for Injection
This product is a compound preparation, its components are: glycyrrhizic acid, cysteine hydrochloride, and glycine.
Name Description Content CAS NO. Registered Holders
Glycyrrhizic acid

Anti-inflammatory effects: (1) Anti-allergic effects: It can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects; (2) Inhibitory effect on arachidonic acid metabolic enzymes: It can directly bind to phospholipase A2, the starting enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

Anti-inflammatory effects: (1) Anti-allergic effects: It can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects; (2) Inhibitory effect on arachidonic acid metabolic enzymes: It can directly bind to phospholipase A2, the starting enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

1405-86-3 1
L-Cysteine monohydrochloride

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

52-89-1 10
Glycine

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

56-40-6 27
Lansoprazole
Name Description Content CAS NO. Registered Holders
Lansoprazole

Extract from the above information

More

Extract from the above information

103577-45-3 88
Compound Captopril Tablets
This product is a compound preparation, whose components are: (1) Captopril 1-[(2S)-2-toluene-3-mercapto-1-oxypropyl]-L-proline; (2) Hydrochlorothiazide 6-chloro-3.4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide.
Name Description Content CAS NO. Registered Holders
Captopril

It mainly inhibits the activity of angiotensin converting enzyme, lowers the level of angiotensin II, reduces the secretion of aldosterone, dilates arteries and veins, achieves a antihypertensive effect and reduces the preload and afterload of the heart to improve cardiac function.

More

It mainly inhibits the activity of angiotensin converting enzyme, lowers the level of angiotensin II, reduces the secretion of aldosterone, dilates arteries and veins, achieves a antihypertensive effect and reduces the preload and afterload of the heart to improve cardiac function.

62571-86-2 28
Hydrochlorothiazide

It mainly increases the excretion of sodium chloride by the kidneys, thereby playing a diuretic role, reducing blood volume and exerting a blood pressure lowering effect.

More

It mainly increases the excretion of sodium chloride by the kidneys, thereby playing a diuretic role, reducing blood volume and exerting a blood pressure lowering effect.

58-93-5 56
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.